Top news of the week: 18.11.2021.
Career And Jobs
Nicki Vasquez, Sutro Biopharma
Sutro Biopharma's Chief Portfolio Strategy and Alliance Officer Nicki Vasquez returned to her roots in oncology when she joined the company in 2015.
MassBio® Survey Establishes First-of-its-Kind, Massachusetts-Specific Biopharma Workforce Demographic Data
November 17, 2021 (CAMBRIDGE, MA) – The Massachusetts Biotechnology Council (MassBio®) today released a report on the state of diversity and the opportunities to grow inclusion and equity ...
BioSpace's Inaugural Best Places to Work Report Reveals Industry's Top Choice Employers
This year’s top 30 large and small companies operate in some of the Life Sciences’ hottest spaces – precision medicine, vaccines, gene editing, genomics and oncology.
Backed by Sean Harper and Beth Seidenberg, an LA biotech scores a massive $250M crossover ahead of 2022 IPO
When Acelyrin closed its Series A late last year, it was met with little fanfare. The biotech had only two employees, the former R&D chief and CBO of Horizon Therapeutics, and didn’t even ...
'I bleed Biogen': Just months after the big biotech was slammed after the controversial OK of aducanumab, R&D chief Al Sandrock makes an abrupt exit
Two years after Al Sandrock jumped from CMO to the top post in R&D — and just months after the hyper-controversial approval of the experimental Alzheimer's drug aducanumab (Aduhelm) — ...
Does biopharma support the Califf nom for FDA? Yeah, whatever
Now that President Joe Biden has drug his heels as long as possible in selecting a new FDA commissioner, we’re set to welcome the new boss — same as the old boss. Janet Woodcock, whose ...
Gerngross biotech Ankyra Therapeutics nabs $45M series B to jump into the clinic, hires new CMO
Little startup Ankyra has grabbed a relatively small $45 million B round as it plots getting its leading oncology hopeful into the clinic.
Jocelynn Pearl, Lady Scientist Podcast and Tune Therapeutics
For years, Jocelynn Pearl was involved behind the scene in inspiring conversations with fellow women in science. So why weren’t those conversations being shared to lift up the next ...